Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction), Application (Drug Discovery, Diagnostic, Research), End User (Pharmaceutical, Hospital, Academic), Offering (Instrument, Consumables, Software) - Global Forecast to 2031

Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction), Application (Drug Discovery, Diagnostic, Research), End User (Pharmaceutical, Hospital, Academic), Offering (Instrument, Consumables, Software) - Global Forecast to 2031


Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction) Application (Drug Discovery, Diagnostic, Research) End User (Pharmaceutical, Hospital, Academic) Offering (Instrument, Consumable, Software)—Global Forecast to 2031

The global genomics market is projected to reach $70.52 billion by 2031, at a CAGR of 11.1% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the genomics market is driven by the rising prevalence of genetic diseases, the increasing incorporation of genomic data in clinical workflows, increasing funding and investments in genomics projects, the growing applications of genomics in the healthcare sector, rising pharmaceutical R&D expenditures, decreasing cost of sequencing, and increasing healthcare spending. However, the lack of standardized approaches in genomics and concerns over the security & privacy of genomic data restrain the growth of this market.

Moreover, the rising adoption of personalized medicines and gene therapies is expected to generate market growth opportunities. However, the shortage of skilled bioinformatics and genomics personnel and the commercialization and scaling of genomic technologies are major challenges for market stakeholders.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020–2024). The key players operating in the global genomics market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Eppendorf SE (Germany), Myriad Genetics, Inc. (U.S.), Revvity, Inc. (Formerly PerkinElmer, Inc.) (U.S.), and BGI Genomics Co. Ltd (China).

Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to the increasing prevalence of genetic diseases, growing adoption of genetic testing, and recurring purchase of consumables over instruments. An increase in the prevalence of genetic disease cases has triggered the demand for genetic tests, which is driving the adoption of consumables. For instance, according to a report published by MJH Life Sciences (U.S.) in 2022, approximately 300,000 babies are born with sickle cell disease per year globally, and nearly 5% of the world's population is affected by the disease.

Among all the technologies studied in this report, in 2024, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the genomics market. The increasing use of PCR in clinical diagnostics, technological advancements in PCR, collaborations for genomic research, and the use of PCR in these research studies are some of the factors contributing to the segment’s largest share. Product launches further boost this segment’s large market share. For instance, in March 2023, Bio-Rad Laboratories launched PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers to optimize PCR applications such as sequencing, cloning, and genotyping.

Among all the applications studied in this report, in 2024, the diagnostics segment is expected to account for the largest share of the genomics market. The use of genomics in oncology, newborn screening, and hepatitis testing is contributing to the largest share of the segment. Genomics is used in newborn screening, which are laboratory tests performed on newborn babies to identify known genetic diseases. Government agencies support newborn screening to reduce the incidence of genetic disorders among newborns through early detection, diagnosis, and intervention. For instance, in December 2022, the government of the U.K. invested more than USD 110.6 million (GBP 105 million) to speed up the rare disease diagnosis in newborns. Such initiatives play a vital role in driving the segment’s largest share.

Among all the end users studied in this report, the pharmaceutical & biotechnology companies’ segment is expected to record the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to the increasing research & development by pharmaceutical & biotechnology companies, the rising utilization of genomics for research processes, and an increasing number of biotechnology companies. Moreover, the rising incidence of chronic diseases has accelerated the need to expedite drug development processes, further propelling the adoption of genomics among pharmaceutical companies.

An in-depth analysis of the geographical scenario of the global genomics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the genomics market. North America is home to numerous renowned research institutions, universities, and organizations dedicated to genomics research; the region has made significant contributions to cancer genomics, with rising pharmaceutical R&D expenditure and the presence of key players. For instance, R&D spending by pharmaceutical companies in Canada for drug discovery has increased, driving the demand for genomics. For instance, in 2020, total R&D expenditure in Canada’s pharmaceutical sector was estimated at between USD 1.8 billion and USD 2.4 billion, compared to USD 1.6 billion and USD 2.2 billion in 2019. Thus, the presence of research institutes, rising testing for genetic disorders, and increasing pharmaceutical R&D expenditure is supporting the largest regional share.

Scope of the Report:

Genomics Market Assessment—by Offering


Systems
Consumables
Software
Services

Genomics Market Assessment—by Technology

Polymerase Chain Reaction (PCR)
Sequencing
NGS
Other Sequencing Technologies
Nucleic Acid Extraction and Purification
Microarray
Other Technologies

Note: Other sequencing technologies include pyrosequencing, degradome sequencing, sanger sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing.

Note: Other technologies include cell counting, transfection, and gene editing.

Genomics Market Assessment—by Application

Diagnostics
Drug Discovery & Development
Life Sciences Research
Cancer Research
Stem Cell Research
Other Life Sciences Research
Other Applications

Note: Other life sciences research applications include cardiovascular research, osteoporosis, immunology, neurobiology, cellular and molecular biology, and diabetes

Note: Other applications include agriculture, forensics, and environmental.

Genomics Market Assessment—by End User

Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Diagnostics Laboratories
Contract Research Organizations (CROs)
Academic & Research Institutes
Other End Users

Note: Other end users include food & beverage companies, agriculture companies, and forensics.

Genomics Market Assessment—by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Genomics Market by Technology - Report Summary
Report MetricsDetails
Years Considered2016 - 2021
Base Year2023
Forecast Period2024-2031
Page Count320
Segments/Key Topicsby Offering
Instruments
Consumables
Software
Services

by Technology
Polymerase Chain Reaction (PCR)
Sequencing

NGS

Other Sequencing Technologies
Nucleic Acid Extraction and Purification
Microarray
Other Technologies

Note: Other sequencing technologies include pyrosequencing, degradome sequencing, sanger sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing.

Note: Other technologies include cell counting, transfection, and gene editing.

by Application
Diagnostics
Drug Discovery & Development
Life Sciences Research

Cancer Research
Stem Cell Research
Other Life Sciences Research
Other Applications
Note: Other life sciences research applications include cardiovascular research, osteoporosis, immunology, neurobiology, cellular and molecular biology, and diabetes
Note: Other applications include agriculture, forensics, and environmental applications.
by End User
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Diagnostics Laboratories
Contract Research Organizations (CROs)
Academic & Research Institutes
Other End Users
Note: Other end users include food & beverage companies, agriculture companies, and forensics.
Regions CoveredNorth America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America (Brazil, Mexico, RoLATAM), and Middle East & Africa
Key Companies MentionedAgilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Eppendorf SE (Germany), Myriad Genetics, Inc. (U.S.), Revvity, Inc. (Formerly PerkinElmer, Inc.) (U.S.), and BGI Genomics Co. Ltd (China).


Key questions answered in the report:

What is the focus of the global genomics market study?


This study offers a detailed assessment of the genomics market, including the market sizes & forecasts for various segmentation such as offering, technology, application, end user, and geography. This report also involves the value analysis of various segments and subsegments of the genomics market at the regional and country levels.

What is the revenue generated from genomics across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The global genomics market is projected to reach $70.52 billion by 2031, at a CAGR of 11.1% during the forecast period.

Which offering segment is expected to account for the largest share of the market in 2024?

Based on offering, in 2024, the consumables segment is expected to account for the largest share of the market due to the high demand for consumables from the increasing number of genetic testing and quality control processes.

Which end-user segment is expected to account for the largest share of the market in 2024?

Based on end user, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest market share due to the increased R&D spending by pharmaceutical companies.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global genomics market?

The growth of the genomics market is driven by the rising prevalence of genetic diseases, the increasing incorporation of genomic data in clinical workflows, increasing funding and investments in genomics projects, the growing applications of genomics in the healthcare sector, rising pharmaceutical R&D expenditures, decreasing cost of sequencing, and increasing healthcare spending.

Moreover, the rising adoption of personalized medicines and gene therapies is expected to generate market growth opportunities.

Who are the major players operating in the global genomics market?

The key players profiled in the global genomics market report are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Eppendorf SE (Germany), Myriad Genetics, Inc. (U.S.), Revvity, Inc. (Formerly PerkinElmer, Inc.) (U.S.), and BGI Genomics Co. Ltd (China).

Which regions/countries are expected to offer significant growth opportunities for the market players operating in the global genomics market?

Emerging economies in the Asia-Pacific region are projected to offer significant growth opportunities to the market players due to increasing cases of inherited diseases such as Down syndrome, colon (colorectal) cancer, and breast cancer, growing awareness about the significance of genetic tests, increasing healthcare expenditure, increasing government initiatives for promoting genetic tests, and growing investments by major market players.


1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Prevalence of Genetic Diseases and the Incorporation of Genomic Data in Clinical Workflows Driving Market Growth
4.2.1.2. Concerns Over the Security & Privacy of Genomic Data Limiting the Adoption of Genomics Products
4.2.1.3. Rising Adoption of Personalized Medicines and Gene Therapies
4.2.1.4. Commercializing and Scaling Genomic Technologies Remain Major Challenges for Market Stakeholders
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Genomics Market: Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.2.1. Shift From Pre-Approval to A Lifecycle Approach
4.4.2.2. Classification Changes
4.4.2.3. Stronger Supervision
4.4.2.4. Clearer Rights and Responsibilities for Economic Operators
4.4.2.5. Traceability/EUDAMED
4.4.2.6. General Safety and Performance Requirements
4.4.2.7. Performance Evaluation and Clinical Evidence
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East & Africa
4.4.6. Guidelines and Regulations for Gene Therapy and Genome Editing
4.5. Pricing Analysis
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Genomics Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.3. Instruments
5.4. Software
5.5. Services
6. Genomics Market Assessment—by Technology
6.1. Overview
6.2. Polymerase Chain Reaction (PCR)
6.3. Sequencing
6.3.1. Next-Generation Sequencing (NGS)
6.3.2. Other Sequencing Technologies
6.4. Nucleic Acid Extraction & Purification
6.5. Microarray
6.6. Other Technologies
7. Genomics Market Assessment—by Application
7.1. Overview
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4. Life Sciences Research
7.4.1. Cancer Research
7.4.2. Stem Cell Research
7.4.3. Other Life Sciences Research
7.5. Other Applications
8. Genomics Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Clinics
8.4. Diagnostic Laboratories
8.5. Contract Research Organizations (CROs)
8.6. Academic & Research Institutes
8.7. Other End Users
9. Genomics Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest Of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest Of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis
10.5.1. Thermo Fisher Scientific Inc. (U.S.)
10.5.2. Illumina, Inc. (U.S.)
10.5.3. Qiagen N.V. (Netherlands)
11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Illumina, Inc
11.3. Qiagen N.V.
11.4. Danaher Corporation
11.5. Agilent Technologies, Inc.
11.6. Bio-Rad Laboratories, Inc.
11.7. Pacific Biosciences of California, Inc.
11.8. Oxford Nanopore Technologies plc
11.9. Eppendorf SE
11.10. Myriad Genetics, Inc.
11.11. Reevity, Inc. (Formerly PerkinElmer, Inc.)
11.12. BGI Genomics Co.,Ltd.
(Note: SWOT Analysis of Top 5 Companies is Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
Table 1 Regulatory Authorities Governing Genomic Products, by Country/Region
Table 2 Guidelines for Gene Therapy and Genome Editing, by Regulatory Body
Table 3 Pricing: Genomics Instruments
Table 4 Pricing: Genomics Consumables
Table 5 Average Selling Prices: Genomics Instruments
Table 6 Average Selling Prices: Genomics Consumables
Table 7 Global Genomics Market, by Offering, 2022–2031 (USD Million)
Table 8 Global Genomics Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Genomics Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Genomics Software Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Genomics Services Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Genomics Market, by Technology, 2022–2031 (USD Million)
Table 13 Global Genomics Market for Polymerase Chain Reaction, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Genomics Market for Sequencing, by Type, 2022–2031 (USD Million)
Table 15 Global Genomics Market for Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Genomics Market for Next-Generation Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Genomics Market for Other Sequencing Technologies, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Genomics Market for Nucleic Acid Extraction and Purification, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Genomics Market for Microarrays, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Genomics Market for Other Technologies, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Genomics Market, by Application, 2022–2031 (USD Million)
Table 22 Global Genomics Market for Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Genomics Market for Drug Discovery and Development, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Genomics Market for Life Sciences Research, by Type, 2022–2031 (USD Million)
Table 25 Global Genomics Market for Life Sciences Research, by Country/Region, 2022–2031 (USD Million)
Table 26 Number of New Cancer Cases, by Region, 2020 Vs. 2040 (In Million)
Table 27 Global Genomics Market for Cancer Research, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Genomics Market for Stem Cell Research, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Genomics Market for Other Life Sciences Research, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Genomics Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Genomics Market, by End User, 2022–2031 (USD Million)
Table 32 Global Genomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Genomics Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Genomics Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Genomics Market for Contract Research Organizations (CROs) by Country/Region, 2022–2031 (USD Million)
Table 36 Global Genomics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Genomics Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 39 North America: Genomics Market, by Country, 2022–2031 (USD Million)
Table 40 North America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 41 North America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 42 North America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 43 North America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 44 North America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 45 North America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 46 U.S.: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 47 U.S.: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 48 U.S.: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 49 U.S.: Genomics Market, by Application, 2022–2031 (USD Million)
Table 50 U.S.: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 51 U.S.: Genomics Market, by End User, 2022–2031 (USD Million)
Table 52 Canada: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 53 Canada: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 54 Canada: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 55 Canada: Genomics Market, by Application, 2022–2031 (USD Million)
Table 56 Canada: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 57 Canada: Genomics Market, by End User, 2022–2031 (USD Million)
Table 58 Europe: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 59 Europe: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 60 Europe: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 61 Europe: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 62 Europe: Genomics Market, by Application, 2022–2031 (USD Million)
Table 63 Europe: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 64 Europe: Genomics Market, by End User, 2022–2031 (USD Million)
Table 65 Germany: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 66 Germany: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 67 Germany: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 68 Germany: Genomics Market, by Application, 2022–2031 (USD Million)
Table 69 Germany: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 70 Germany: Genomics Market, by End User, 2022–2031 (USD Million)
Table 71 France: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 72 France: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 73 France: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 74 France: Genomics Market, by Application, 2022–2031 (USD Million)
Table 75 France: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 76 France: Genomics Market, by End User, 2022–2031 (USD Million)
Table 77 U.K.: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 78 U.K.: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 79 U.K.: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 80 U.K.: Genomics Market, by Application, 2022–2031 (USD Million)
Table 81 U.K.: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 82 U.K.: Genomics Market, by End User, 2022–2031 (USD Million)
Table 83 Italy: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 84 Italy: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 85 Italy: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 86 Italy: Genomics Market, by Application, 2022–2031 (USD Million)
Table 87 Italy: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 88 Italy: Genomics Market, by End User, 2022–2031 (USD Million)
Table 89 Spain: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 90 Spain: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 91 Spain: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 92 Spain: Genomics Market, by Application, 2022–2031 (USD Million)
Table 93 Spain: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 94 Spain: Genomics Market, by End User, 2022–2031 (USD Million)
Table 95 Rest of Europe: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 96 Rest of Europe: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 97 Rest of Europe: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 98 Rest of Europe: Genomics Market, by Application, 2022–2031 (USD Million)
Table 99 Rest of Europe: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 100 Rest of Europe: Genomics Market, by End User, 2022–2031 (USD Million)
Table 101 Asia-Pacific: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 102 Asia-Pacific: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 103 Asia-Pacific: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 104 Asia-Pacific: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 105 Asia-Pacific: Genomics Market, by Application, 2022–2031 (USD Million)
Table 106 Asia-Pacific: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 107 Asia-Pacific: Genomics Market, by End User, 2022–2031 (USD Million)
Table 108 China: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 109 China: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 110 China: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 111 China: Genomics Market, by Application, 2022–2031 (USD Million)
Table 112 China: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 113 China: Genomics Market, by End User, 2022–2031 (USD Million)
Table 114 Japan: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 115 Japan: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 116 Japan: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 117 Japan: Genomics Market, by Application, 2022–2031 (USD Million)
Table 118 Japan: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 119 Japan: Genomics Market, by End User, 2022–2031 (USD Million)
Table 120 India: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 121 India: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 122 India: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 123 India: Genomics Market, by Application, 2022–2031 (USD Million)
Table 124 India: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 125 India: Genomics Market, by End User, 2022–2031 (USD Million)
Table 126 Rest of Asia-Pacific: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 127 Rest of Asia-Pacific: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 128 Rest of Asia-Pacific: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 129 Rest of Asia-Pacific: Genomics Market, by Application, 2022–2031 (USD Million)
Table 130 Rest of Asia-Pacific: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 131 Rest of Asia-Pacific: Genomics Market, by End User, 2022–2031 (USD Million)
Table 132 Latin America: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 133 Latin America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 134 Latin America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 135 Latin America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 136 Latin America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 137 Latin America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 138 Latin America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 139 Brazil: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 140 Brazil: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 141 Brazil: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 142 Brazil: Genomics Market, by Application, 2022–2031 (USD Million)
Table 143 Brazil: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 144 Brazil: Genomics Market, by End User, 2022–2031 (USD Million)
Table 145 Mexico: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 146 Mexico: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 147 Mexico: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 148 Mexico: Genomics Market, by Application, 2022–2031 (USD Million)
Table 149 Mexico: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 150 Mexico: Genomics Market, by End User, 2022–2031 (USD Million)
Table 151 Rest of Latin America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 152 Rest of Latin America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 153 Rest of Latin America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 154 Rest of Latin America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 155 Rest of Latin America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 156 Rest of Latin America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 157 Middle East & Africa: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 158 Middle East & Africa: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 159 Middle East & Africa: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 160 Middle East & Africa: Genomics Market, by Application, 2022–2031 (USD Million)
Table 161 Middle East & Africa: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 162 Middle East & Africa: Genomics Market, by End User, 2022–2031 (USD Million)
Table 163 Recent Developments, by Company, 2020–2024
Figure 1 Research Process
Figure 2 Secondary Sources Referred for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Dem and Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 9 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Genomics Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Healthcare Expenditure as A Percentage of GDP in Major Countries, 2015 Vs. 2020
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2022 (USD Billion)
Figure 15 Estimated Number of New Cancer Cases, by Region, 2020 Vs. 2030 (in Thousand)
Figure 16 Percentage of FDA Approvals for Personalized Medicine, 2015-2021
Figure 17 USFDA Regulatory Pathways for Genomic Products
Figure 18 EU Regulatory Pathway IVDR 2017/746
Figure 19 China: Medical Device Classification and Pre-Market Requirements for IVD Devices
Figure 20 Porter's Five Forces Analysis
Figure 21 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 22 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 23 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 24 Global Pharmaceutical R&D Expenditure, 2014—2026 (USD Billion)
Figure 25 Cancer Incidence Cases, 2020 Vs. 2040
Figure 26 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 27 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 28 Global Genomics Market Assessment, by Region, 2024 Vs. 2031 (USD Million)
Figure 29 North America: Genomics Market Snapshot
Figure 30 Europe: Genomics Market Snapshot
Figure 31 Asia-Pacific: Genomics Market Snapshot
Figure 32 Latin America: Genomics Market Snapshot
Figure 33 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 34 Genomics Market: Competitive Benchmarking, by Offering
Figure 35 Genomics Market: Competitive Benchmarking, by Geography
Figure 36 Competitive Dashboard: Genomics Market
Figure 37 Global Genomics Market Share Analysis, by Key Players
Figure 38 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 39 Illumina, Inc.: Financial Overview (2022)
Figure 40 Qiagen N.V.: Financial Overview (2022)
Figure 41 Danaher Corporation: Financial Overview (2022)
Figure 42 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 43 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 44 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 45 Oxford Nanopore Technologies plc.: Financial Overview (2022)
Figure 46 Eppendorf SE: Financial Overview (2022)
Figure 47 Myriad Genetics, Inc.: Financial Overview (2022)
Figure 48 PerkinElmer, Inc.: Financial Overview (2022)
Figure 49 BGI Genomics Co.,Ltd.: Financial Overview (2022)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings